AstraZeneca

gold arrow pointing upward forward
Biotech

Biophama VC, deal values and exits all rise in Q3: Pitchbook

Biopharma brought in $7.2 billion across 187 deals in 2024's third quarter, jumping from $5.8 billion in the second quarter.
Gabrielle Masson Nov 20, 2024 6:15am
heart cardio cardiovascular heart health

Lilly's lipoprotein-blocking heart drug posts midstage trial win

Nov 19, 2024 9:55am
AstraZeneca

AstraZeneca, Daiichi pull lung cancer BLA for Enhertu follow-up

Nov 12, 2024 5:27am
AZ

AstraZeneca still 'playing to win' in obesity, execs say

Nov 4, 2024 11:49am
scrapheap

AZ licenses discarded rare disease drug to Monopar Therapeutics

Oct 24, 2024 2:54pm
Merck Co headquarters

With trial win, Merck looks to take on Sanofi, AZ in RSV

Oct 17, 2024 6:00pm